Search research articles
Contact Us
Filters
Showing results (31-40 of 50) with videos related to
Page
of 5
Sort By:
Cellular Immunology
|
February 1, 1980
The enhancement of humoral and cellular immune responses by dimethyldioctadecylammonium bromide
W C Gordon, M D Prager, M C Carroll
Shock (Augusta, Ga.)
|
August 1, 1997
Anti-platelet action of nitric oxide and selective phosphodiesterase inhibitors
M K Sly, R C Eberhart, M D Prager
Biochimica Et Biophysica Acta
|
January 14, 1976
The influence of glutamine, its decomposition products, and glutaminase on the transformation of human and mouse lymphocytes
F S Baechtel, D E Gregg, M D Prager
American Journal of Surgery
|
October 1, 1971
The infusion of Ringer's lactate solution during shock. Changes in lactate, excess lactate, and pH
P C Canizaro, M D Prager, G T Shires
Cancer Research
|
October 1, 1971
Immunization with chemically modified lymphoma cells
M D Prager, I Derr, A Swann, et al.
European Journal of Immunology
|
June 1, 1979
Identification of autoanti-Thi-1 antibody in the sera of BALB/c mice immune to P1798 lymphoma
F S Baechtel, M D Prager, E S Vitetta
The Journal of Burn Care & Rehabilitation
|
July 1, 1991
Elastase and alpha 1-protease inhibitor in burn wound exudates
M D Prager, M Herring, B Germany, et al.
Cancer Letters
|
June 1, 1985
Effect of dimethyldioctadecylammonium bromide induced macrophages on malignant cell proliferation
M D Prager, M C Kanar, J L Farmer, et al.
Cancer Letters
|
March 1, 1987
Modulation of secreted plasminogen activator activity of human renal carcinoma cells by dimethylsulfoxide, butyrate and retinoate
N F Nelson, W Cieplak, S C Dacus, et al.
International Journal of Cancer
|
May 15, 1977
Immunogenicity of solubilized tumor antigen extracted from P1798 murine lymphoma cells or isolated from tumor-bearer ascites fluid and reactivity with anti-thy-1.2 antiserum
W C Gordon, F S Baechtel, G Goetz, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 50) with videos related to
Sort By:
Page
of 5
Cellular Immunology
|
February 1, 1980
The enhancement of humoral and cellular immune responses by dimethyldioctadecylammonium bromide
W C Gordon, M D Prager, M C Carroll
Shock (Augusta, Ga.)
|
August 1, 1997
Anti-platelet action of nitric oxide and selective phosphodiesterase inhibitors
M K Sly, R C Eberhart, M D Prager
Biochimica Et Biophysica Acta
|
January 14, 1976
The influence of glutamine, its decomposition products, and glutaminase on the transformation of human and mouse lymphocytes
F S Baechtel, D E Gregg, M D Prager
American Journal of Surgery
|
October 1, 1971
The infusion of Ringer's lactate solution during shock. Changes in lactate, excess lactate, and pH
P C Canizaro, M D Prager, G T Shires
Cancer Research
|
October 1, 1971
Immunization with chemically modified lymphoma cells
M D Prager, I Derr, A Swann, et al.
European Journal of Immunology
|
June 1, 1979
Identification of autoanti-Thi-1 antibody in the sera of BALB/c mice immune to P1798 lymphoma
F S Baechtel, M D Prager, E S Vitetta
The Journal of Burn Care & Rehabilitation
|
July 1, 1991
Elastase and alpha 1-protease inhibitor in burn wound exudates
M D Prager, M Herring, B Germany, et al.
Cancer Letters
|
June 1, 1985
Effect of dimethyldioctadecylammonium bromide induced macrophages on malignant cell proliferation
M D Prager, M C Kanar, J L Farmer, et al.
Cancer Letters
|
March 1, 1987
Modulation of secreted plasminogen activator activity of human renal carcinoma cells by dimethylsulfoxide, butyrate and retinoate
N F Nelson, W Cieplak, S C Dacus, et al.
International Journal of Cancer
|
May 15, 1977
Immunogenicity of solubilized tumor antigen extracted from P1798 murine lymphoma cells or isolated from tumor-bearer ascites fluid and reactivity with anti-thy-1.2 antiserum
W C Gordon, F S Baechtel, G Goetz, et al.
Page
of 5